Vanda Pharmaceuticals to Announce Second Quarter 2018 Financial Results on August 1, 2018
Conference Call and Webcast to Follow
Get Alerts VNDA Hot Sheet
Join SI Premium – FREE
WASHINGTON, July 17, 2018 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced it will release results for the second quarter of 2018 on Wednesday, August 1, 2018, after the market closes.
Vanda will host a conference call at 4:30 PM ET on Wednesday, August 1, 2018, during which management will discuss the second quarter 2018 financial results and other corporate activities. To participate in the conference call, please dial 1-800-708-4539 (domestic) or 1-847-619-6396 (international) and use passcode 47289344.
The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Wednesday, August 1, 2018, beginning at 7:00 PM ET and will be accessible until Wednesday, August 8, 2018, at 11:59 PM ET. The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers. The passcode number is 47289344.
ABOUT VANDA PHARMACEUTICALS INC.:Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.
Investor Contact:Jim KellyExecutive Vice President & Chief Financial OfficerVanda Pharmaceuticals Inc.(202) 734-3428[email protected]
View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-second-quarter-2018-financial-results-on-august-1-2018-300682389.html
SOURCE Vanda Pharmaceuticals Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Taiwan Semi (TSM) Q1 profit beats expectations on AI demand
- Future Pak Confirms Proposal to Acquire Vanda Pharmaceuticals for $7.25 to $7.75 Per Share in Cash
- Future Pak Confirms Proposal to Acquire Vanda Pharmaceuticals (VNDA) for $7.25-$7.75/sh Cash
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!